Objective: To determine the antibody response to oligodendrocyte-specific p
rotein (OSP) in patients with MS. Background: OSP is a recently identified
CNS-specific myelin protein that is abundant and therefore a candidate auto
antigen in MS. Methods: The presence of anti-OSP antibodies was determined
using Western blot analysis, peptide blots, and ELISA in patients with MS a
nd in other neurologic and normal control subjects. Results: Using Western
blot analysis, seven patients with relapsing-remitting MS (RRMS) were found
to contain anti-OSP antibodies in their CSF that were not present in contr
ol subjects. Peptide mapping determined that the antibody response was dire
cted to a seven aa peptide (OSP 114-120), which has 71% homology with sever
al common pathogenic proteins. Using OSP 114-120 as antigen, ELISAs were pe
rformed on CSF from 85 MS and 51 control patients. Eighty percent of the sa
mples from RRMS patients followed at the University of California at Los An
geles had an ELISA reading above 0.55 optical density units, whereas all 20
control CSF samples had values less than 0.55 U. Similar results were foun
d in specimens from an outside research bank. ELISAs performed on CSF using
homologous viral peptides as antigen showed a close correlation with anti-
OSP 114-120 ELISA readings, and in some, the readings were higher than thos
e using OSP peptides. Conclusions: There is a specific humoral response dir
ected against a region of OSP in RRMS patients that cross-reacts with sever
al common viral peptides. This suggests a possible role for molecular mimic
ry in the development of MS.